According to FutureWise analysis the market for Antacids in 2023 was US$ 7.59 billion, and is expected to reach US$ 10.89 billion by 2031 at a CAGR of 4.60%.
Antacids are over-the-counter medications designed to alleviate symptoms of heartburn and indigestion by neutralizing excess stomach acid. They are particularly effective in providing rapid relief from discomfort associated with acid reflux, gastroesophageal reflux disease (GERD), and certain types of ulcers. The primary mechanism of action involves the inhibition of pepsin, an enzyme that plays a key role in the digestion of proteins and is activated in an acidic environment.
Antacids are available in two popular formats: liquid preparations and chewable tablets. Each form offers a convenient option for alleviating heartburn and indigestion. The liquid varieties tend to provide quicker relief and can coat the stomach lining, while chewable tablets offer convenience for those who prefer a portable option. Users often experience a rapid reduction in symptoms such as burning sensations in the stomach or chest, a feeling of bloating or fullness, a sour or acidic taste in the mouth, and mild discomfort in the chest or stomach area.
While antacids are generally safe for the majority of adults, certain groups should exercise caution. Individuals on low-sodium diets, those taking other medications, children younger than 12 years, pregnant women, and people with heart conditions like heart failure or high blood pressure, as well as those with liver or kidney diseases, should seek guidance from their healthcare provider before using these medications.
The dosages of antacids can vary significantly based on the user's age and the specific indications for use, therefore it is crucial to follow the instructions provided on the packaging closely. Healthcare professionals may also recommend different formulations or dosages based on individual health needs or potential interactions with other medications, ensuring a safe and effective treatment approach.
FutureWise Market Research has published a report that provides an insightful analysis of Antacids Market trends that are affecting the overall market growth.
Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=9137&type=requestsample
Antacids Market Segmentation:
By Drug Class
- Proton Pump Inhibitors
- H2 Antagonists
- Acid Neutralizers
By Formulation
- Tablets
- Liquid
- Powder
- Others
By Distribution Channel
- Hospital Pharmacies
- Retain Pharmacies
- Others
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Competitive Landscape in Antacids Market:
- AstraZeneca
- Bayer AG
- Boehringer Ingelheim GmbH
- Dr. Reddy's Laboratories Ltd.
- GlaxoSmithKline plc
- Johnson and Johnson
- Pfizer Inc.
- Procter and Gamble
- Reckitt Benckiser Group plc
- Sanofi
- Sun Pharmaceuticals Ltd
- Takeda Pharmaceutical
- Valeant Pharmaceuticals International, Inc.
Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=9137&license=multi
**Objectives of this Study: **
- To provide a comprehensive analysis of the Antacids Market By Drug Class, By Formulation, By Distribution Channel and By Region.
- To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
- To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
- To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Flexible Delivery Model:
- We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
- The customization services offered are free of charge with the purchase of any license of the report.
- You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com
